ストックスクリーナーアプリを入手
3.78
4.13%
0.15
プレマーケット:
3.71
-0.07
-1.85%
前日終値:
$3.63
開ける：
$3.65
24時間の取引高:
554.20K
Relative Volume:
0.70
時価総額：
$289.49M
収益：
$4.72B
当期純損益:
$-123.85M
株価収益率:
-0.2644
EPS:
-14.2981
ネットキャッシュフロー:
$-303.12M
1週間 パフォーマンス:
+14.55%
1か月 パフォーマンス:
+23.13%
6か月 パフォーマンス:
+50.00%
1年 パフォーマンス:
-82.02%
1日の値動き範囲:
$3.61
$3.84
1週間の範囲:
$3.27
$3.84
52週間の値動き範囲:
$1.885
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
名前
Accendra Health Inc
セクター
電話
(804) 277-4304
住所
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
3.78 | 289.49M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
841.31 | 98.50B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
307.99 | 59.92B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.72 | 53.57B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
88.26 | 10.05B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.56 | 1.34B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | ダウングレード | UBS | Buy → Neutral |
| 2024-07-19 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-12 | ダウングレード | BofA Securities | Buy → Underperform |
| 2022-10-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 再開されました | Citigroup | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-30 | 再開されました | JP Morgan | Underweight |
| 2022-03-23 | アップグレード | HSBC Securities | Reduce → Hold |
| 2021-04-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-03-08 | アップグレード | Goldman | Sell → Buy |
| 2020-12-17 | アップグレード | UBS | Neutral → Buy |
| 2020-09-25 | アップグレード | Barclays | Underweight → Equal Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-01-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | ダウングレード | Goldman | Neutral → Sell |
| 2019-11-15 | アップグレード | CLSA | Underperform → Outperform |
| 2019-09-06 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-04-03 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-01-18 | アップグレード | HSBC Securities | Hold → Buy |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-15 | アップグレード | CLSA | Underperform → Outperform |
| 2018-12-14 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | ダウングレード | Goldman | Buy → Neutral |
| 2018-09-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | ダウングレード | CLSA | Outperform → Sell |
| 2018-04-10 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | アップグレード | Goldman | Sell → Neutral |
| 2017-11-02 | ダウングレード | HSBC Securities | Buy → Hold |
| 2016-03-24 | アップグレード | Goldman | Sell → Neutral |
| 2015-12-07 | ダウングレード | Goldman | Neutral → Sell |
| 2015-08-31 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | 開始されました | HSBC Securities | Underweight |
| 2009-08-05 | アップグレード | Citigroup | Sell → Buy |
| 2008-12-01 | ダウングレード | HSBC Securities | Neutral → Underweight |
すべてを表示
Accendra Health Inc (ACH) 最新ニュース
Enterprise value to EBIT forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Enterprise value to EBIT forward of Accendra Health Inc – GETTEX:6OM - TradingView
Accendra Health files prospectus for $200M mixed shelf - scanx.trade
Form S-3 Accendra Health Inc For: 15 July By Investing.com - Investing.com Nigeria
Accendra Health Files $200 Million Mixed Shelf Registration - Moomoo
Price to earnings forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health (ACH) Has Home-Care Scale, but the Debt Stack Drives the Risk - AlphaStreet
Price to earnings forward of Accendra Health Inc – SWB:6OM - TradingView
Enterprise value to revenue forward of Accendra Health Inc – SWB:6OM - TradingView
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Concludes Exchange Offers for Senior Notes Due 2029 and 2030 - sekbernews.id
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Price to sales forward of Accendra Health Inc – SWB:6OM - TradingView
Accendra Health (ACH) Sheds 1.5% as Shares Approach Key Support ZoneLow Volume Node - dars.gov.et
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Accendra Health Inc. Q1 2026 Earnings: EPS Beats Estimates but Stock DeclinesEarnings Turnaround - DonanımHaber
Accendra Health, Inc.(NYSE: ACH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Index - marketscreener.com
Accendra Health Inc Actuals & Estimates (NYSE:ACH) - TradingView
ACHAccendra Health Inc Options - Finviz
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Value Benchmark - marketscreener.com
Accendra Health Completes Major Exchange Offer, Restructures Debt - TipRanks
Accendra Health reports near-complete tenders in exchange offers, issues new secured notes - TradingView
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health Reports Expiration of Exchange Offers, Final Tender Results - Moomoo
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
ACH Q1 2026 Earnings: EPS Beat Drives Positive Market Response Despite Revenue UncertaintyEPS Estimate Trend - dars.gov.et
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accendra Health Inc. (ACH) Q1 2026 Earnings: Strong EPS Beat Signals Operational ImprovementFiscal Year Earnings - dars.gov.et
Accendra Health Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes - Minichart
Accendra Health Completes Major Debt Exchange and Refinancing - TipRanks
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue DisclosureEarnings Per Share - newsline.com
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Australia
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health secures 99% participation in exchange offers - scanx.trade
Accendra Health (ACH) Gains 4.71% as Momentum Builds Toward Key Resistance ZoneStock Surge Alerts - dars.gov.et
Are Options Traders Betting on a Big Move in Accendra Health Stock? - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats by 60.9% but Stock Declines on Revenue UncertaintyFinancial Data - newsline.com
Accendra Health (ACH) Q4 2025 earnings summary - Quartr
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates by 60.9% as Loss Narrows to $0.04 Per ShareConsensus Forecast Report - newsline.com
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com Nigeria
Owens & Minor Appoints Jim Marshall as Chief Executive Officer, Effective May 27, 2026 - marketscreener.com
Owens & Minor names former McKesson SVP as new CEO - MassDevice
Accendra Health announces exchange offer, consent solicitations - HME News
Accendra Health Q1 2026 Earnings: EPS Beat Drives Positive Market ReactionShare Repurchase Impact - The Legal Advocate
Accendra Health launches debt exchange offer, seeks new financing By Investing.com - Investing.com Australia
Accendra Health launches debt exchange offer, seeks new financing - Investing.com UK
Accendra Health Inc (ACH) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
0.79%
大文字化:
|
ボリューム (24 時間):